Results 181 to 190 of about 11,478,693 (361)

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
PRDX2 acts as a central redox hub linking metabolic dysfunction‐associated steatohepatitis (MASH) to hepatocellular carcinoma (HCC). In normal hepatocytes, PRDX2 maintains redox balance and metabolic homeostasis under oxidative stress. In contrast, during malignant transformation, PRDX2 promotes oncogenic signaling, stemness, and tumor initiation ...
Naroa Goikoetxea‐Usandizaga   +2 more
wiley   +1 more source

IHD risk score. [PDF]

open access: yesCirculation, 1980
H S, Rosman, B A, Blumenstein
openaire   +2 more sources

PB1015 Venous Thromboembolism in Patients with Newly Diagnosed Lymphoma and Its Association with ThroLy and Khorana Risk Scores

open access: gold, 2023
W. Wan Mohd Zohdi   +4 more
openalex   +1 more source

A Cardiovascular Risk Score for Use in Occupational Medicine [PDF]

open access: gold, 2021
Giuseppina Affinito   +5 more
openalex   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

Risk score roulette: A cautionary tale of polygenic risk score reliability. [PDF]

open access: yesJ Alzheimers Dis
Xue D   +4 more
europepmc   +1 more source

Personalized Risk Scoring for Critical Care Prognosis using Mixtures of Gaussian Processes [PDF]

open access: green, 2016
Ahmed M. Alaa   +3 more
openalex   +1 more source

Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.

open access: yesChest, 2019
R. Benza   +10 more
semanticscholar   +1 more source

Tumor mutational burden as a determinant of metastatic dissemination patterns

open access: yesMolecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy